ONMDW
OneMedNet Corp
– (–)0.03USD1成交股數1.5M市值–本益比(近四季)1.0股價營收比+88.4%營收年增(近四季)–下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 4 · 1.2M · 3 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 0 · 0 · 0 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 2.7M · 0 |
| 近 180 天 淨額 | 2.7M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-10 | 09-14 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 143K | 0.63 | 90K | 8.9M | SEC |
| 2026-07-30 | 08-07 | Kosasa Thomas | Director,TenPercentOwner | P 公開市場買進 | 1.4M | 0.69 | 1,000K | 18.5M | SEC |
| 2026-06-23 | 06-24 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 159K | 0.63 | 100K | 8.8M | SEC |
| 2026-06-23 | 06-24 | Green Aaron | Chief Executive Officer | P 公開市場買進 | 36.6K | 0.57 | 21K | 1.9M | SEC |
| 2026-06-16 | 06-17 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 172K | 0.58 | 100K | 8.6M | SEC |
| 2026-06-15 | 06-16 | Green Aaron | Chief Executive Officer | P 公開市場買進 | 18.7K | 0.54 | 10K | 1.9M | SEC |
| 2026-06-12 | 06-16 | Green Aaron | Chief Executive Officer | P 公開市場買進 | 36.9K | 0.56 | 21K | 1.8M | SEC |
| 2026-06-12 | 06-15 | Kosasa Thomas | Director,TenPercentOwner | P 公開市場買進 | 159K | 0.63 | 100K | 17.1M | SEC |
| 2026-05-18 | 05-20 | Kosasa Thomas | Director,TenPercentOwner | P 公開市場買進 | 269K | 0.93 | 250K | 16.9M | SEC |
| 2026-04-23 | 04-24 | Kosasa Thomas | Director,TenPercentOwner | P 公開市場買進 | 281K | 0.89 | 250K | 16.7M | SEC |
| 2026-04-01 | 04-24 | Yu Jeffrey | Chief Medical Officer | A 獲配股票 | 219K | 0.83 | 182K | 8.4M | SEC |
| 2026-04-01 | 04-24 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 904K | 0.83 | 750K | 8.2M | SEC |
| 2026-02-06 | 04-24 | Kosasa Thomas | Director,TenPercentOwner | P 公開市場買進 | 595K | 0.84 | 500K | 16.4M | SEC |
| 2025-11-26 | 11-26 | Casaburi Eric | Director | A 獲配股票 | 45.0K | – | – | 110K | SEC |
| 2025-11-26 | 11-26 | Yu Jeffrey | Chief Medical Officer | A 獲配股票 | 45.0K | – | – | 7.3M | SEC |
| 2025-11-26 | 11-26 | Kosasa Thomas | Director | A 獲配股票 | 45.0K | – | – | 15.8M | SEC |
| 2025-11-26 | 11-26 | Alleyne Kenneth | Director | A 獲配股票 | 38.2K | – | – | 38.2K | SEC |
| 2025-11-26 | 11-26 | Clarke Jair | Director | A 獲配股票 | 45.0K | – | – | 138K | SEC |
| 2025-11-26 | 11-26 | Green Aaron | Chief Executive Officer | A 獲配股票 | 45.0K | – | – | 1.9M | SEC |
| 2025-11-26 | 11-26 | McCraw Sherry Coonse | Director | A 獲配股票 | 45.0K | – | – | 56.3K | SEC |
| 2025-11-26 | 11-26 | Golden Robert Lawrence | Chief Financial Officer | A 獲配股票 | 45.0K | – | – | 548K | SEC |
| 2025-11-26 | 11-26 | Zeinfeld Andrew B | Director | A 獲配股票 | 45.0K | – | – | 382K | SEC |
| 2025-11-24 | 11-26 | Yu Jeffrey | Chief Medical Officer | A 獲配股票 | 200K | – | – | 7.3M | SEC |
| 2025-11-24 | 11-26 | Golden Robert Lawrence | Chief Financial Officer | A 獲配股票 | 33.3K | – | – | 503K | SEC |
| 2025-11-24 | 11-26 | Green Aaron | Chief Executive Officer | A 獲配股票 | 1.0M | – | – | 1.9M | SEC |
| 2025-11-24 | 11-26 | Golden Robert Lawrence | Chief Financial Officer | A 獲配股票 | 300K | – | – | 470K | SEC |
| 2025-11-18 | 12-23 | Green Aaron | Chief Executive Officer | S 公開市場賣出 | 61.6K | 1.20 | 74K | 1.8M | SEC |
| 2025-10-22 | 12-23 | Green Aaron | Chief Executive Officer | S 公開市場賣出 | 64.8K | 2.23 | 144K | 1.9M | SEC |
| 2025-10-15 | 11-26 | Casaburi Eric | Director | P 公開市場買進 | 10.0K | 3.05 | 31K | 65.5K | SEC |
| 2025-09-25 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 1.3K | 1.03 | 1K | 7.1M | SEC |
| 2025-09-24 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 17.2K | 1.02 | 18K | 7.1M | SEC |
| 2025-09-24 | 11-26 | Kosasa Thomas | Director | P 公開市場買進 | 6.0K | 0.93 | 6K | 15.7M | SEC |
| 2025-09-23 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 5.7K | 0.93 | 5K | 7.1M | SEC |
| 2025-09-22 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 400 | 0.95 | 380.00 | 7.1M | SEC |
| 2025-09-19 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 1.3K | 0.89 | 1K | 7.1M | SEC |
| 2025-09-18 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 700 | 0.91 | 637.00 | 7.1M | SEC |
| 2025-09-05 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 2.1K | 0.86 | 2K | 7.1M | SEC |
| 2025-09-04 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 11.8K | 0.87 | 10K | 7.1M | SEC |
| 2025-09-03 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 11.7K | 0.81 | 9K | 7.0M | SEC |
| 2025-09-02 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 24.3K | 0.85 | 21K | 7.0M | SEC |
| 2025-08-29 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 10.9K | 0.82 | 9K | 7.0M | SEC |
| 2025-08-29 | 11-26 | Kosasa Thomas | Director | P 公開市場買進 | 581K | 0.86 | 500K | 15.7M | SEC |
| 2025-08-28 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 17.0K | 0.80 | 14K | 7.0M | SEC |
| 2025-08-27 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 21.4K | 0.69 | 15K | 7.0M | SEC |
| 2025-08-26 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 173K | 0.69 | 120K | 7.0M | SEC |
| 2025-08-25 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 13.3K | 0.75 | 10K | 6.8M | SEC |
| 2025-08-21 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 15.0K | 0.77 | 12K | 6.8M | SEC |
| 2025-08-19 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 16.5K | 0.77 | 13K | 6.8M | SEC |
| 2025-06-20 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 1.7M | 0.42 | 700K | 6.7M | SEC |
| 2025-06-20 | 11-26 | Kosasa Thomas | Director | P 公開市場買進 | 1.2M | 0.42 | 500K | 15.2M | SEC |
| 2025-06-19 | 11-26 | Yu Jeffrey | Chief Medical Officer | C 轉換 | 1.8M | 0.71 | 1.3M | 5.1M | SEC |
| 2025-06-19 | 11-26 | Kosasa Thomas | Director | C 轉換 | 2.1M | 0.75 | 1.6M | 11.1M | SEC |
| 2025-06-19 | 11-26 | Kosasa Thomas | Director | C 轉換 | 2.9M | 0.71 | 2.0M | 14.0M | SEC |
| 2025-06-17 | 11-26 | Green Aaron | Chief Executive Officer | C 轉換 | 240K | 1.14 | 274K | 885K | SEC |
| 2025-06-17 | 11-26 | Yu Jeffrey | Chief Medical Officer | C 轉換 | 479K | 1.14 | 546K | 3.2M | SEC |
| 2025-06-17 | 11-26 | Kosasa Thomas | Director | C 轉換 | 493K | 1.14 | 562K | 9.0M | SEC |
| 2025-06-16 | 11-26 | Kosasa Thomas | Director | P 公開市場買進 | 55.0K | 0.38 | 21K | 8.5M | SEC |
| 2025-04-21 | 11-26 | Kosasa Thomas | Director | P 公開市場買進 | 47.0K | 0.49 | 23K | 8.4M | SEC |
| 2025-01-31 | 11-26 | Golden Robert Lawrence | Chief Financial Officer | A 獲配股票 | 24.3K | – | – | 170K | SEC |
| 2025-01-01 | 11-26 | Zeinfeld Andrew B | Director | A 獲配股票 | 82.1K | – | – | 337K | SEC |
| 2025-01-01 | 11-26 | Clarke Jair | Director | A 獲配股票 | 82.1K | – | – | 93.5K | SEC |
| 2024-12-18 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 100 | 0.99 | 99.00 | 2.8M | SEC |
| 2024-11-20 | 11-26 | Casaburi Eric | Director | P 公開市場買進 | 1.3K | 0.87 | 1K | 55.5K | SEC |
| 2024-11-12 | 11-26 | Casaburi Eric | Director | P 公開市場買進 | 500 | 0.85 | 425.00 | 54.2K | SEC |
| 2024-10-01 | 11-26 | McCraw Sherry Coonse | Director | A 獲配股票 | 11.3K | – | – | 11.3K | SEC |
| 2024-10-01 | 11-26 | Clarke Jair | Director | A 獲配股票 | 11.3K | – | – | 11.3K | SEC |
| 2024-10-01 | 11-26 | Yu Jeffrey | Chief Medical Officer | A 獲配股票 | 231K | 0.57 | 132K | 2.8M | SEC |
| 2024-09-20 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 1.6K | 0.66 | 1K | 2.5M | SEC |
| 2024-09-18 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 800 | 0.68 | 544.00 | 2.5M | SEC |
| 2024-08-30 | 11-26 | Golden Robert Lawrence | Chief Financial Officer | A 獲配股票 | 100K | – | – | 145K | SEC |
| 2024-08-21 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 100 | 1.22 | 122.00 | 2.5M | SEC |
| 2024-08-16 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 14 | 1.41 | 19.74 | 2.5M | SEC |
| 2024-08-15 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 10 | 1.34 | 13.40 | 2.5M | SEC |
| 2024-08-14 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 13 | 1.35 | 17.55 | 2.5M | SEC |
| 2024-08-14 | 11-26 | Zeinfeld Andrew B | Director | A 獲配股票 | 17.3K | – | – | 254K | SEC |
| 2024-08-13 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 2.2K | 1.19 | 3K | 2.5M | SEC |
| 2024-08-12 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 913 | 1.10 | 1K | 2.5M | SEC |
| 2024-07-08 | 11-26 | Casaburi Eric | Director | P 公開市場買進 | 4.1K | 0.92 | 4K | 53.7K | SEC |
| 2024-05-10 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 1.2K | 0.52 | 625.56 | 2.5M | SEC |
| 2024-05-08 | 11-26 | Yu Jeffrey | Chief Medical Officer | P 公開市場買進 | 105 | 0.69 | 72.45 | 2.5M | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| TORONTO DOMINION BANK | 2.9M | 102K | +3.9K (+0%) | 加碼 |
| Savant Capital, LLC | 872K | 31K | 新進 | 新進 |
| 德劭 D. E. Shaw & Co., Inc. | 420K | 15K | 不變 | 持平 |
| Yakira Capital Management, Inc. | 330K | 11K | 不變 | 持平 |
| Polar Asset Management Partners Inc. | 257K | 9K | 不變 | 持平 |
| RIVERNORTH CAPITAL MANAGEMENT, LLC | 129K | 5K | 不變 | 持平 |
| Clear Street Group Inc. | 83.7K | 3K | 不變 | 持平 |
| WHITEBOX ADVISORS LLC | 49.7K | 2K | 不變 | 持平 |
| TWO SIGMA SECURITIES, LLC | 19.1K | 658.00 | −2.9K (-13%) | 減碼 |
| UBS Group AG | 2.0K | 69.00 | −700 (-26%) | 減碼 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 10 -3 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 1 / 4 / 0 / 2 |
| 機構合計持股 · 佔流通股 | 5.1M · 8.6% |
| 合計季末市值 | 179K |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 11.3K |
|---|---|
| 與上期比 | -19.5% |
| 佔流通股數 | 0.02% |
| 日均成交量 | 2.1K |
| 回補天數 | 5.5 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 11.3K | -19.5% | 0.02% | 2.1K | 5.5 |
| 2026-08-14 | 14.0K | -0.7% | 0.02% | 2.0K | 7.2 |
| 2026-07-31 | 14.1K | -7.0% | 0.02% | 5.8K | 2.4 |
| 2026-07-15 | 15.2K | +8.5% | 0.03% | 1.9K | 7.9 |
| 2026-06-30 | 14.0K | 0.0% | 0.02% | 449 | 31.1 |
| 2026-06-15 | 14.0K | -4.1% | 0.02% | 5.5K | 2.5 |
| 2026-05-29 | 14.6K | +4.0% | 0.02% | 3.3K | 4.5 |
| 2026-05-15 | 14.0K | -14.7% | 0.02% | 3.6K | 3.9 |
| 2026-04-30 | 16.4K | -7.9% | 0.03% | 17.7K | 1.0 |
| 2026-04-15 | 17.8K | -27.6% | 0.03% | 5.6K | 3.2 |
| 2026-03-31 | 24.6K | -0.8% | 0.04% | 1.4K | 17.4 |
| 2026-03-13 | 24.8K | -4.0% | 0.04% | 5.5K | 4.5 |
| 2026-02-27 | 25.9K | -0.5% | 0.04% | 8.7K | 3.0 |
| 2026-02-13 | 26.0K | -14.3% | 0.04% | 5.5K | 4.7 |
| 2026-01-30 | 30.3K | -1.3% | 0.05% | 21.8K | 1.4 |
| 2026-01-15 | 30.7K | -8.9% | 0.05% | 4.7K | 6.6 |
| 2025-12-31 | 33.7K | +21.7% | 0.06% | 9.6K | 3.5 |
| 2025-12-15 | 27.7K | +29.3% | 0.05% | 23.3K | 1.2 |
| 2025-11-28 | 21.4K | +9.8% | 0.04% | 48.0K | 1.0 |
| 2025-11-14 | 19.5K | +10.6% | 0.03% | 10.9K | 1.8 |
| 2025-10-31 | 17.7K | -48.2% | 0.03% | 43.0K | 1.0 |
| 2025-10-15 | 34.1K | +38.4% | 0.06% | 265K | 1.0 |
| 2025-09-30 | 24.6K | -36.2% | 0.04% | 77.1K | 1.0 |
| 2025-09-15 | 38.6K | +50.1% | 0.07% | 11.2K | 3.4 |
| 2025-08-29 | 25.7K | -22.2% | 0.04% | 18.2K | 1.4 |
| 2025-08-15 | 33.1K | +1747.0% | 0.06% | 57.7K | 1.0 |